Transcutaneous Bilirubin Measurements in Neonates Post Phototherapy
Launched by NHS GREATER GLASGOW AND CLYDE · Jan 20, 2021
Trial Information
Current as of May 15, 2025
Unknown status
Keywords
ClinConnect Summary
Jaundice is common in the newborn and may result in the need for babies to be readmitted from home for phototherapy, with associated increased costs and significant family distress.
As well as prolonged hospital stay, neonates on phototherapy require multiple blood tests (SBR), generally acquired via heel prick testing. These cause the baby discomfort and samples may be insufficient or haemolyzed and require repeating. There is also a delay of one to two hours at best in results being received and actioned.
Jaundice measurements can also be obtained using non-invasive, cheap and reliable ...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Well neonates
- • 35+0 weeks gestation or greater, over 24 hours old
- • Inpatients at Princess Royal Maternity (PRM), NHS Greater Glasgow and Clyde
- Exclusion Criteria:
- • Unwell neonates
- • Less than 35+0 weeks' gestation
- • Less than 24 hours old
- • Mother unable or too distressed to give informed consent
About Nhs Greater Glasgow And Clyde
NHS Greater Glasgow and Clyde (NHS GG&C) is one of the largest health organizations in the UK, dedicated to delivering high-quality healthcare services to a diverse population. As a clinical trial sponsor, NHS GG&C plays a pivotal role in advancing medical research and improving patient outcomes through innovative clinical studies. The organization is committed to upholding rigorous ethical standards and regulatory compliance, ensuring that all trials are conducted with the utmost care for participant safety and scientific integrity. With a focus on collaboration, NHS GG&C partners with academic institutions, healthcare professionals, and industry stakeholders to foster an environment conducive to groundbreaking research and the development of new therapies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials